<VariationArchive RecordType="classified" VariationID="3441" VariationName="NM_000135.2:c.1471_1626del" VariationType="Deletion" Accession="VCV000003441" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-09-03" DateCreated="2019-02-17" MostRecentSubmission="2019-02-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="18480" VariationID="3441">
      <GeneList>
        <Gene Symbol="FANCA" FullName="FA complementation group A" GeneID="2175" HGNC_ID="HGNC:3582" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>16q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="89737549" stop="89816647" display_start="89737549" display_stop="89816647" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="89803958" stop="89883064" display_start="89803958" display_stop="89883064" Strand="-" />
          </Location>
          <OMIM>607139</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000135.2:c.1471_1626del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16q24.3</CytogeneticLocation>
      </Location>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000135.2" sequenceAccession="NM_000135" sequenceVersion="2" change="c.1471_1626del">
            <Expression>NM_000135.2:c.1471_1626del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_495t1" sequenceAccession="LRG_495t1" change="c.1471_1626del">
            <Expression>LRG_495t1:c.1471_1626del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="607139.0003" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 8896564 Fig. 2 to determine the location of this allele on the current reference sequence.</Comment>
      <Comment DataSource="NCBI curation" Type="GenomicLocationNotEstablished">Deletion of 2 exons from FANCA cDNA (16-17 of NM_000135.2), removing 52 amino acids. Genomic sequencing not given in PubMed 8896564.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000135.2:c.1471_1626del AND Fanconi anemia complementation group A" Accession="RCV000003610" Version="4">
        <ClassifiedConditionList TraitSetID="883">
          <ClassifiedCondition DB="MedGen" ID="C3469521">Fanconi anemia complementation group A</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1996-11-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1996-11-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-02-17" MostRecentSubmission="2019-02-17">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">8896564</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="883" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9887" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Fanconi anemia, group A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Fanconi anemia complementation group A</ElementValue>
                <XRef ID="MONDO:0009215" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FANCA</ElementValue>
                <XRef Type="MIM" ID="227650" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Fanconi anemia (FA) is characterized by physical abnormalities, bone marrow failure, and increased risk for malignancy. Physical abnormalities, present in approximately 75% of affected individuals, include one or more of the following: short stature, abnormal skin pigmentation, skeletal malformations of the upper and/or lower limbs, microcephaly, and ophthalmic and genitourinary tract anomalies. Progressive bone marrow failure with pancytopenia typically presents in the first decade, often initially with thrombocytopenia or leukopenia. The incidence of acute myeloid leukemia is 13% by age 50 years. Solid tumors – particularly of the head and neck, skin, and genitourinary tract – are more common in individuals with FA.</Attribute>
                <XRef ID="NBK1401" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301575</ID>
                <ID Source="BookShelf">NBK1401</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301753</ID>
                <ID Source="BookShelf">NBK5192</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="FARF, 2008">
                <URL>http://www.fanconi.org/images/uploads/other/Guidelines_for_Diagnosis_and_Management.pdf</URL>
                <CitationText>Fanconi Anemia Research Fund, Guidelines for Diagnosis and Management, 2008 (See 2020 Update)</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="FARF, 2020">
                <URL>https://www.fanconi.org/images/uploads/other/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.pdf</URL>
                <CitationText>Fanconi Anemia Clinical Care Guidelines, Fifth Edition.</CitationText>
              </Citation>
              <XRef ID="84" DB="Orphanet" />
              <XRef ID="C3469521" DB="MedGen" />
              <XRef ID="MONDO:0009215" DB="MONDO" />
              <XRef Type="MIM" ID="227650" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="23768" SubmissionDate="2019-02-14" DateLastUpdated="2019-02-17" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="607139.0003_FANCONI ANEMIA, COMPLEMENTATION GROUP A" title="FANCA, 156-BP DEL, NT1515_FANCONI ANEMIA, COMPLEMENTATION GROUP A" />
        <ClinVarAccession Accession="SCV000023768" DateUpdated="2019-02-17" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1996-11-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">The Fanconi Anaemia/Breast Cancer Consortium (1996) identified in 2 families with Fanconi anemia (FANCA; 227650) a deletion in the FANCA gene of 156 bp (from nucleotides 1515 to 1670) that spans 2 exons. One patient was of African American origin and one was of northern European origin (and a compound heterozygote for another deletion; see 607139.0004). This 156-bp deletion did not result in a frameshift but led to the deletion of 52 amino acids from the protein. The deletion was not found in 70 control chromosomes, suggesting to the investigators that it did not represent alternative splicing.</Attribute>
              <Citation>
                <ID Source="PubMed">8896564</ID>
              </Citation>
              <XRef DB="OMIM" ID="227650" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FANCA" />
          </GeneList>
          <Name>FANCA, 156-BP DEL, NT1515</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">156-BP DEL, NT1515</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="607139.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">FANCONI ANEMIA, COMPLEMENTATION GROUP A</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="23768" TraitType="Disease" MappingType="Name" MappingValue="FANCONI ANEMIA, COMPLEMENTATION GROUP A" MappingRef="Preferred">
        <MedGen CUI="C3469521" Name="Fanconi anemia complementation group A" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

